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ABSTRACT
Modulating the host response is a promising approach to treating influenza, caused by a virus whose pathogenesis is determined
in part by the reaction it elicits within the host. Though the pathogenicity of emerging H7N9 influenza virus in several animal
models has been reported, these studies have not included a detailed characterization of the host response following infection.
Therefore, we characterized the transcriptomic response of BALB/c mice infected with H7N9 (A/Anhui/01/2013) virus and com-
pared it to the responses induced by H5N1 (A/Vietnam/1203/2004), H7N7 (A/Netherlands/219/2003), and pandemic 2009 H1N1
(A/Mexico/4482/2009) influenza viruses. We found that responses to the H7 subtype viruses were intermediate to those elicited
by H5N1 and pdm09H1N1 early in infection but that they evolved to resemble the H5N1 response as infection progressed.
H5N1, H7N7, and H7N9 viruses were pathogenic in mice, and this pathogenicity correlated with increased transcription of cyto-
kine response genes and decreased transcription of lipid metabolism and coagulation signaling genes. This three-pronged tran-
scriptomic signature was observed in mice infected with pathogenic H1N1 strains such as the 1918 virus, indicating that it may
be predictive of pathogenicity across multiple influenza virus strains. Finally, we used host transcriptomic profiling to computa-
tionally predict drugs that reverse the host response to H7N9 infection, and we identified six FDA-approved drugs that could
potentially be repurposed to treat H7N9 and other pathogenic influenza viruses.
IMPORTANCE
Emerging avian influenza viruses are of global concern because the human population is immunologically naive to them. Cur-
rent influenza drugs target viral molecules, but the highmutation rate of influenza viruses eventually leads to the development
of antiviral resistance. As the host evolves far more slowly than the virus, and influenza pathogenesis is determined in part by the
host response, targeting the host response is a promising approach to treating influenza. Here we characterize the host transcrip-
tomic response to emerging H7N9 influenza virus and compare it with the responses to H7N7, H5N1, and pdm09H1N1. All three
avian viruses were pathogenic in mice and elicited a transcriptomic signature that also occurs in response to the legendary 1918
influenza virus. Our work identifies host responses that could be targeted to treat severe H7N9 influenza and identifies six FDA-
approved drugs that could potentially be repurposed as H7N9 influenza therapeutics.
Avian influenza virus strains with the potential to acquire hu-man-to-human transmission are of global concern. Since the
first human case of highly pathogenic avian H5N1 influenza virus
was documented in China in 1997, there have been over 600 cases
(1). More than half were fatal, primarily as a result of virus trans-
mission from domestic poultry to humans (1). Despite the sever-
ity of disease and high fatality rate, H5N1 cases have remained
sporadic, likely due to poor human-to-human transmissibility of
the virus (2, 3). H7 subtype viruses have caused numerous small
outbreaks over the past few decades (4–6). Notably, an H7N7
outbreak occurred in 2003 in the Netherlands, causing 89 con-
firmed human infections and 1 death (5). In early 2013, H7N9
avian influenza virus emerged in China, causing over 400 cases of
influenza and more than 100 deaths between February 2013 and
February 2014 (7–11). Phylogenetic analysis demonstrated that
the novel H7N9 virus is a triple reassortant comprising a hemag-
glutinin (HA) froman avianH7N3 virus, the neuraminidase (NA)
of an avian H7N9 virus, and all six internal genes from an avian
H9N2 virus (10).
Though reports describe H7N9 viruses as less pathogenic than
H5N1 in humans and animal models, H7N9 viruses are more
transmissible than H5N1 in the direct-contact ferret model (12–
16). Furthermore, some H7N9 viruses are able to bind human
(2,6-sialic acid) and avian (2,3-sialic acid) receptors, though
their avidity for human receptors is low (13–15, 17–19). In addi-
tion, H7N9 elicits a transcriptomic response intermediary to that
induced by H5N1 or a human seasonal virus in cultured human
airway epithelial cells, suggesting adaptation of H7N9 to its hu-
man host (20). These observations, combined with the fact that
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H7N9 is more pathogenic than seasonal influenza virus strains,
have sparked global concern (1, 11).
Influenza virus pathogenicity is due in part to the cytopathic
effects of viral replication and the tissue damage that arises from
an overly robust immune response. 1918 H1N1, which caused the
deadliest recorded influenza pandemic, is thought to have caused
severe disease and death in part because it elicited a highly aber-
rant immune response in the host (21). H5N1, which is evenmore
pathogenic than 1918 H1N1 in mice, elicits a stronger and more
accelerated response that is distinguishable from the response to
1918 H1N1 because of an earlier induction of inflammatory cyto-
kine and lipoxin signaling genes (22).
There have been multiple reports characterizing the pathoge-
nicity of H7N9 in different animal models, but these studies have
not included detailed transcriptomic characterization of the host
response. Additionally, no such characterization has been done
for H7N7 (A/Netherlands/219/2003), an H7 subtype virus that
was isolated from a fatal case of influenza and has a lethality sim-
ilar to that of H7N9 in mammals (23–26). We previously con-
ducted transcriptional profiling of the host response to H7N9 and
H7N7 in cultured airway epithelial cells, which serve as amodel of
lung epithelial cells, and used it to predict new anti-H7N9 mole-
cules (20). However, since multiple cell types participate in the
host response to influenza, considering the contribution of differ-
ent cell types to host response and disease progression delivers
additional targets for host-directed interventions. We character-
ized, for the first time, the lung transcriptomic response of BALB/c
mice infected with H7N9 (A/Anhui/1/2013) and compared it to
the responses elicited by H5N1 (A/Vietnam/1203/2004), H7N7
(A/Netherlands/219/2003), and pdm09H1N1 (A/Mexico/4482/
2009).
We found that lung responses toAnhui1 andNL219were over-
all most similar to each other and intermediate to those elicited by
VN1203 and Mex4482. Though H7N7 induced a more robust
interferon and cytokine response than did H7N9 on day 1, the
responses of the three avian viruses were remarkably similar later
on in infection. All three avian viruses were pathogenic in mice,
and increased pathogenicity correlated with increased induction
of cytokine response genes and decreased transcription of lipid
metabolism and coagulation signaling genes. This three-pronged
transcriptomic signature may be predictive of influenza pathoge-
nicity in mice across different viral strains, since it also occurs in
response to 1918H1N1 andmouse-adapted pdm09H1N1 (A/Cal-
ifornia/04/2009) virus (27). Finally, we used host transcriptional
profiles to computationally identify drugs that may have thera-
peutic effects against H7N9 infection, identifying six FDA-ap-
proved drugs that could potentially be repurposed as H7N9 influ-
enza therapeutics.
MATERIALS AND METHODS
Viruses. Three avian-origin influenza viruses isolated from fatal human
cases, A/Anhui/01/2013 (H7N9), A/Netherlands/219/2003 (H7N7), and
A/Vietnam/1203/2004 (H5N1), and apandemic 2009H1N1 (pdm09H1N1)
human virus, A/Mexico/4482/2007, were used in this study. Virus stocks
were grown in the allantoic cavities of 10-day-old embryonated hen’s eggs
for 24 to 28 h (high-pathogenicity avian influenza virus [HPAI]) or 48 h
(low-pathogenicity avian influenza virus [LPAI]) at 37°C for avian-origin
influenza viruses or for 48 h at 34°C for the pdm09H1N1 virus. Allantoic
fluid frommultiple eggswas pooled, clarified by centrifugation, aliquoted,
and stored at 70°C. Virus titers were determined by plaque assay as
previously described (28). All research with avian viruses was conducted
under biosafety level 3 containment, including enhancements required by
the U.S. Department of Agriculture and the Select Agent Program (http:
//www.cdc.gov/od/ohs/biosfty/bmbl5/bmbl5toc.htm).
Mouse infections. Six- to 8-week-old BALB/c mice were purchased
from Charles River Laboratories (Wilmington, MA). All experiments
were performed under biosafety level 3 enhanced containment.Micewere
anesthetized with 2,2,2-tribromoethanol in tert-amyl alcohol (Avertin;
Sigma-Aldrich, St. Louis,MO) and then inoculated intranasallywith 50l
of phosphate-buffered saline (mock infection) or with 105 PFU of virus in
a 50-l volume. Six animals in each virus-inoculated group were moni-
tored formorbidity andmortality asmeasured by weight loss and survival
over a period of 14 days. For transcriptomic profiling, mouse lungs were
harvested from 5 virus-infected and 3 mock-infected mice on days 1, 3,
and 5 postinfection. For viral titer measurements, lungs were collected
from 4 virus-infected mice at each time point on days 1, 3, and 5 postin-
oculation. Animal research was conducted under the guidance of the
CDC’s Institutional Animal Care andUseCommittee in an animal facility
accredited by the Association for Assessment and Accreditation of Labo-
ratory Animal Care International.
Histopathology. Lung sections were fixed by submersion in 10%neu-
tral buffered formalin, routinely processed, and embedded in paraffin.
Sections weremade at 5mandwere stained with hematoxylin and eosin
(H&E).
RNA isolation and microarray processing. RNA extraction from vi-
rus- and mock-infected BALB/c mice was performed in quadruplicate as
previously described (27). Probe labeling and microarray slide hybridiza-
tion for each biological replicate were performed using theWhole Mouse
Genome Microarray 4x44K kit (Agilent Technologies) according to the
manufacturer’s instructions. Slides were scanned on an Agilent DNAmi-
croarray scanner (model G2505B) using the extended dynamic range
(XDR) setting, and raw images were analyzed using Agilent Feature Ex-
traction software (version 9.5.3.1). Extracted raw data were background
corrected using the “norm-exp” method with an offset of 1 and quantile
normalized using the limma package (29) in the R environment. Repli-
cated probes weremean summarized. All probes were required to pass the
Agilent quality control (QC) flag (“gIsFound,” “gIsWellAboveBG,” “gIs-
Saturated,” “gIsFeatNonUnifOL,” and “gIsFeatPopnOL”) for all replicates
of at least one time point (29,382 probes passed QC filtering). For each
sample, a log2 fold change (log2FC) value was calculated as the difference
between log2-normalized data for this sample and the average of log2-
normalized data for time-matched mock-infected samples. Microarray
annotation was retrieved using the R package mgug4122a.db.
Identification of differentially expressed (DE) genes.Differential ex-
pressionwas determined by comparing influenza virus-infected replicates
to time-matched mock-infected samples based on a linear model fit for
each probe using the R package limma (29). Criteria for differential ex-
pression were an absolute log2FC of 1 and a q value of0.05, calculated
using a moderated t test with subsequent Benjamini-Hochberg correc-
tion.
Transcriptomic-distance analysis. To visualize the differences among
biological samples in a 2-dimensional space, we used multidimensional
scaling (MDS) representation (30). Euclidian distances between tran-
scriptomics profiles were calculated based on normalized data, and non-
metric MDS was performed with the MASS package in R Bioconductor
(31) to map the distances into the 2-dimensional space with minimal loss
of information (evaluated byKruskal’s stress). Biological replicates from a
same condition were linked in convex hulls (i.e., polygons) using the
function “chull” in R.
Functional enrichment and drug prediction. Functional analysis of
statistically significant gene expression changes was performed using In-
genuity Pathway Analysis (IPA; Ingenuity Systems). For all gene set en-
richment analyses, a right-tailed Fisher exact test was used to calculate the
probability that enrichment of each biological function was due to chance
alone. All enrichment scores were calculated in IPA using the probes that
passed our QC filter as the background data set. IPA upstream regulator
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analysis, which is based on prior knowledge of expected effects between
regulators and their known target genes according to the IPA database,
was used to predict regulators and infer their activation state. The Z score
determines whether gene expression changes for known targets of each
regulator are consistent with what is expected from the literature (Z
score  2) or if the changes are anticorrelated with the literature (Z
score2). To predict potential antivirals, the IPA database was queried
with lists ofDE genes fromdays 1 and 3 postinoculation inH7N9-infected
mice, and we selected all the molecules annotated “drugs and chemicals”
with Z scores less than 2. Z scores for the other three viruses were also
noted (data not shown).
Computationalmeasurement of immune cell subsets.Topredict the
immune cell composition of the virus-infected lungs, we defined immune
cell genes as those genes that were expressed 20-fold more in an immune
cell type than in lung tissue based on microarray data from GeneAtlas v3.
Interferon-stimulated genes were removed from these lists so as to only
consider genes specific to immune cells. The enrichment score (ES) forDE
genes in each of these immune subsets was calculated as the log10(P
value) determined by the Fisher exact test. High ES in a specific immune
cell population, e.g., granulocyte, indicates that a large number of genes
upregulated after infection are highly expressed in granulocytes compared
to lungs and therefore may result from granulocyte infiltration of the
lungs.
Microarray data accession number. Raw microarray data were de-
posited in NCBI’s Gene Expression Omnibus under accession number
GSE54048.
RESULTS
H7N9, H7N7, and H5N1 are more pathogenic than pdm09H1N1
despite having similar replication levels. Previous reports have
described human isolates of H7N9, H7N7, and H5N1 as highly
pathogenic in BALB/c mice (13, 14, 19, 23, 25, 26, 32–36). To
corroborate those findings and directly compare the replica-
tion levels and pathogenicities of the viruses, BALB/cmice were
inoculated with 105 PFU of H7N9 (A/Anhui/01/2013), H7N7
(A/Netherlands/219/2003), H5N1 (A/Vietnam/1203/2004), or
pdm09H1N1 (A/Mexico/4482/2007) virus (Fig. 1). The three
avian viruses induced continuous weight loss in the mice, while
Mex4482 did not (Fig. 1A). Mice infected with VN1203 died by 7
days postinoculation, while Anhui1- and NL219-infected mice
died by 8 days postinoculation (Fig. 1B). None of the Mex4482-
inoculatedmice perished. Thus,Mex4482 was not pathogenic at a
dose of 105 PFU in mice, whereas the avian viruses were highly
pathogenic. Notably, the weight loss and survival differences were
not attributable to differences in viral replication, given that all
four viruses replicated to similar levels in the lungs, with titers
peaking at106 PFU/ml on day 3 (Fig. 1C).
The global transcriptional responses to H7N9 andH7N7 are
intermediate to the responses inducedbyH5N1andpdm09H1N1.
To visualize the differences among the transcriptional responses,
we utilized multidimensional scaling (MDS) (Fig. 2A). MDS aims
to represent high-dimensional transcriptional profiles in a two-
dimensional space for visualization purposes. The distance be-
tween two points on an MDS representation is proportional to
their transcriptional difference, with small distances indicating
similarity and large distances indicating dissimilarity. The tran-
scriptional responses formed distinct clusters with respect to time
postinfection and virus strain, indicating that there was consensus
among biological replicates (Fig. 2A).
By focusing on the distance between each experimental condi-
tion (Fig. 2A), wewere able to discern that (i) the host responses to
VN1203 and Mex4482 were the most different from each other;
(ii) the responses to H7 subtype viruses were intermediate to
the responses induced by VN1203 andMex4482, with the Anhui1
response more similar to the Mex4482 response and the NL219
response more similar to the VN1203 response, especially at day 1
postinfection; and (iii) the host responses to the three avian vi-
ruses were remarkably similar to each other on day 3 postinfection
but very different from the response to Mex4482 (Fig. 2A).
H7N9,H7N7, andH5N1 induce amore robust host response
than does pdm09H1N1. To elucidate if the pathogenicity of each
virus was related to the timing and magnitude of the host re-
sponse, we compared the differentially expressed (DE) genes in-
duced by infection with each virus versus mock infection at each
time point (Fig. 2B). Each virus induced the differential expres-
sion of similar numbers of genes at day 1 (Fig. 2B). By day 3, there
were more than 2,000 DE genes in Anhui1-, Mex4482-, and
NL219-infected lungs and over 3,000 DE genes in VN1203-in-
fected lungs (Fig. 2B). At day 5, the avian viruses induced differ-
ential expression of more than 3,000 genes, more than twice the
number observed in Mex4482-infected animals. These data sug-
gest that the host responses to the avian viruses were more robust
and prolonged than the response to Mex4482, and they are con-
sistent with the MDS plot (Fig. 2A), which shows that the Euclid-
FIG 1 H7N9, H7N7, H5N1, and pdm09H1N1 display different pathogenici-
ties but replicate to similar levels in BALB/c mice. BALB/c mice were infected
with 105 PFU of H7N9 (A/Anhui/1/2013), H7N7 (A/Netherlands/219/2003),
H5N1 (A/Vietnam/1203/2004), or pdm09H1N1 (A/Mexico/4482/2009). Fol-
lowing challenge, mice were monitored daily for weight loss (A) and survival
(B) for 14 days. (C) BALB/c lungs were harvested at days 1, 3, and 5 postinfec-
tion, and their viral titers were quantitated using plaque assay (limit of detec-
tion 10 PFU).
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ean distance between Mex4482 and mock infections increased at
day 3 and then decreased on day 5, demonstrating that the re-
sponse to Mex4482 was returning to baseline. Thus, the host re-
sponse toMex4482 appeared to be resolving on day 5, while those
to the avian viruses were progressing.
The H7N9 and H7N7 transcriptional programs share fea-
tures with the pdm09H1N1 program on day 1 postinfection. As
mentioned previously, H7N9 has features that are associated with
human influenza viruses (15, 17). We therefore wanted to assess
the similarity of the host responses toAhnui1 andNL219 to that of
a human virus, Mex4482, and to a prototypic pathogenic avian
virus, VN1203. To do so, we used the manually curated data
within Ingenuity Pathway Analysis (IPA) to identify biological
pathways induced by each of the four viruses. On day 1, none of
the top five pathways that were perturbed by VN1203 (as indi-
cated by enrichment scores) were perturbed by Mex4482, again
suggesting that these two viruses elicited vastly different host re-
sponses (Fig. 3A). However, there was overlap of the pathways
affected by Anhui1, NL219, and Mex4482, indicating that these
viruses were perturbing certain aspects of the host response in
similar ways. For example, genes associated with the coagulation
system and liver X receptor/retinoid X receptor (LXR/RXR) acti-
vation were highly differentially expressed in Anhui1-, NL219-,
and Mex4482-infected lungs. Genes encoding thrombin (F2),
FIG 2 The global transcriptional responses to H7N9 and H7N7 are intermediate to the global transcriptional responses to H5N1 and pdm09H1N1. (A)
Nonparametric multidimensional scaling (MDS) was used to show the Euclidean distance between experimental outcomes. Each mRNA sample is represented
as a single point colored by viral condition andwith different shapes according to timepostinfection.Dotted lines and arrows represent the progression of the host
response over time. The Kruskal stress criterion quantifies the quality of the representation as a fraction of the information lost during the dimensionality
reduction procedure. (B) Number of upregulated and downregulated differentially expressed (DE) genes after infection with influenza virus. The DE genes in
each infected sample were compared to time-matched mock-infected samples. Criteria used for differential expression analysis were a q value of 0.05 as
determined by limma’s empirical Bayes-moderated t test and 	log2FC	1.
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coagulation factor XII (F12), coagulation factor XI B (F11b),
fibrinogen chain alpha (FGA), fibrinogen chain beta (FGB),
and fibrinogen chain gamma (FGG) were expressed at low lev-
els in VN1203-infected mice but were induced in mice infected
with Anhui1, NL219, or Mex4482 (Fig. 3B). LXR/RXR pathway
genes that were differentially expressed encoded molecules
such as apolipoprotein H (APOH), apolipoprotein A2
(APOA2), and apolipoprotein B (APOB), which are compo-
nents of lipid metabolism pathways.
There were, however, subtle differences between the responses
to Anhui1 and NL219 on day 1. The H7 subtype viruses differed
from each other with respect to their effects on interferon signal-
ing (Fig. 3A and C). NL219, but not Anhui1, infection resulted in
the expression of gamma interferon (IFN-
), alpha interferon
(IFNA1/IFNA13), signaling transducer and activator of transcrip-
tion 1 (STAT1), and interferon regulatory factor 1 (IRF1) (Fig.
3B). Notably, the expression of these genes also contributed to the
similarity of the NL219 response to the VN1203 response and of
the Anhui1 response to the Mex4482 response. VN1203-infected
mice showed upregulated transcription of these genes, while
Mex4482-infected mice did not. The induction of cytokine genes
such as those for interleukin 6 (IL-6), CXCL10, and CCL4 also
divided NL219 and Anhui1 on day 1, with NL219 and VN1203
inducing transcription of these genes more highly than Anhui1
and Mex4482 did (Fig. 3C).
One consequence of the cytokine response is the recruitment
of immune cells to the site of infection or damage. We took an
integrative statistical approach to infer and categorize the different
immune cell types that were present in the lungs on day 1. First,
the GeneAtlas v3 database was used to identify genes associated
FIG 3 The H7N9 and H7N7 transcriptional programs differ on day 1 postinfection. The DE genes from Fig. 2 were analyzed with Ingenuity Pathway Analysis
(IPA) to produce lists of host pathways that were most perturbed by infection with each virus at day 1. (A)The top 5 enriched pathways are represented as radial
plots at day 1. The distance from the center in each radial plot represents the enrichment score (ES), which is defined aslog10(P value) using a right-tailed Fisher
exact test. (B) Expression levels of select coagulation and lipid metabolism genes on day 1. (C) Expression levels of select interferon signaling and cytokine genes
on day 1. (D) Computational measurement of immune cell subsets. Genes that were specifically upregulated in immune cells compared to lung tissue were
defined as genes expressed 20-foldmore in each immune cell type than in lungs on day 1 based onmicroarray analysis fromGeneAtlas v3. Enrichment scores for
DE genes in each of these immune subsets was calculated aslog10(P value) determined by Fisher exact test.
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with specific immune cell types. If these genes were induced 20-
fold or more in a sample, we then inferred that immune cell types
that express them were present in the lungs. A high enrichment
score in a specific immune cell population, e.g., granulocytes, in-
dicates that a large number of genes upregulated after infection are
highly expressed in granulocytes compared to lung cells and there-
fore may result from granulocyte infiltration of the lungs. Mast
cells appeared to be recruited to Mex4482-infected lungs (and, to
a lesser extent, to Anhui1-infected lungs) but not to VN1203- and
NL219-infected cells on day 1. Infection with VN1203 or NL219
but not Anhui1 or Mex4482 also appeared to trigger granulocyte
infiltration (Fig. 3C), which has been implicated in influenza
pathogenicity (37, 38). However, the three avian viruses had sim-
ilar pathogenicities inmice, indicating that these day 1 differences
were not determining pathogenicity in these experiments.
The later host responses toH7N9,H7N7, andH5N1 are sim-
ilar to each other but different from the host response to
pdm09H1N1. On day 3, the responses to the avian viruses were
similar to each other but different from the response to Mex4482
(Fig. 4A). Coagulation genes and LXR/RXR pathway genes were
highly upregulated by Mex4482 but not by the avian viruses, sug-
gesting that the avian viruses were potentially suppressing gene
expression in these two pathways. There was also less induction of
proinflammatory cytokine genes in mice infected with Mex4482
versus the others, suggesting that immune cell adhesion and traf-
ficking were preferentially upregulated by the avian viruses (Fig.
4A). This was also reflected in our cellular infiltrate prediction
using Gene Atlas v3; the lungs of Mex4482-infected mice were
predicted to have lower levels of macrophages and granulocytes
(Fig. 4C and D).
By day 5, the responses to all four viruses were overlapping.
However, the ESswere higher forVN1203 versus the other viruses,
indicating that VN1203 had a greater effect on these functional
pathways by either up- or downregulating genes within each path-
way. For example, the coagulation system had an ES of 15.5 in
VN1203-infected mice, while it had ESs of 0.579, 5.94, and 1.54
in Mex4482-, NL219-, and Anhui1-infected mice, respectively.
Mex4482-infected mice had the lowest ES for the cytokine-asso-
ciated pathways associatedwith immune cell recruitment on day 5
(Fig. 4B), corroborating the resolution of the host response to
Mex4482 that was suggested by the MDS plot and the DE gene
analysis (Fig. 2).
We also performed hematoxylin and eosin (H&E) staining on
lung tissue sections from mock-infected and virus-infected mice
to validate the computational prediction of increased immune cell
recruitment in the lungs ofmice infectedwith the avian viruses. At
1, 3, and 5 days postinoculation, lungs from the mock-infected
mice lacked lesions (Fig. 5A). Microscopic lesions were observed
FIG 4 The host responses to the avian viruses are similar at later times postinfection. The DE genes from Fig. 2 were analyzed with Ingenuity Pathway
Analysis (IPA) to produce lists of host pathways that were most perturbed by infection with each virus at day 3 (A) and day 5 (B). The top 5 enriched
pathways are represented as radial plots at each time point. The distance from the center in each radial plots represents the enrichment score (ES) defined
aslog10(P value) using a right-tailed Fisher exact test. (C and D) Computational measurement of immune cell subsets. Genes specifically upregulated
in immune cells compared to lung tissue on day 3 (C) and day 5 (D) were defined as genes expressed 20-fold more in each immune cell type than in lungs
based on microarray analysis from GeneAtlas v3. Enrichment scores for DE genes in each of these immune subsets was calculated as log10(P value)
determined by Fisher exact test.
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FIG 5 Histopathologic changes in tissues from influenza virus-infected mice. Photomicrographs of lung tissue sections stained with hematoxylin and eosin
(magnification,400). (A) Lung tissue from mock-infected mouse on day 1 postinfection. (B) Vacuolation and necrosis of the respiratory epithelium (arrow-
heads) on day 1 in a mouse infected with H7N9 (A/Anhui/1/2013). (C) Moderate bronchiolitis with vacuolation and necrosis of the respiratory epithelium and
associated peribronchiolar granulocytic inflammation (arrowhead) and edema on day 1 in a mouse infected with H5N1 (A/Vietnam/1203/2004). (D) Necrosis
of respiratory epithelium with minimal alveolitis on day 3 in a mouse infected with pdm09H1N1 (A/Mexico/4482/2009). (E) Bronchiolitis with moderate
peribronchial granulocytic alveolitis (arrowhead) on day 3 in a mouse infected with H5N1 (A/Vietnam/1203/2004). (F) Bronchiolitis and mild granulocytic
alveolitis (arrowhead) on day 3 in a mouse infected with H7N7 (A/Netherlands/219/2003). (G) Necrosis of bronchial epithelium with associated granulocytic,
histiocytic, and lymphocytic alveolitis (arrows) on day 3 in a mouse infected with H7N9 (A/Anhui/1/2013). (H) Regeneration of respiratory epithelium
(arrowhead) on day 5 in a mouse infected with H1N1 (A/Mexico/4482/2007).
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in H&E-stained lung tissue sections from infected mice. At day 1,
mice in all four groups had minimal lesions, consisting of vacuo-
lation and mild necrosis of the bronchial and bronchiolar epithe-
lium (Fig. 5B), but twoH5N1-infectedmice also hadmild tomod-
erate peribronchial inflammation and mild accumulation of
granulocytes in alveoli adjacent to bronchioles (Fig. 5C).Onday 3,
all four groups had focal to diffuse bronchiolar epithelial necrosis
with associated peribronchiolar edema and mild to moderate in-
flammatory cell infiltrates (Fig. 5D, E, and F). However, the
pdm09H1N1-infected mice had minimal alveolitis (Fig. 5D),
while the H7N9-infected, H7N7-infected (Fig. 5E), and H5N1-
infected (Fig. 5F)mice hadmild tomoderate alveolitis, with gran-
ulocytes being more common than mononuclear cells. On day 5,
the H7N9-, H7N7-, and H5N1-infected mice had continuing ne-
crosis of bronchiolar epithelium, peribronchiolar edema, and
mild to moderate inflammation, with associated alveolitis (Fig.
5G). The lesions were moderately severe for H5N1- and H7N9-
infectedmice and continued to have significant granulocytic alve-
olitis adjacent to the airways, but macrophages predominated.
The H7N7-infected mice had slightly less severe bronchiolitis and
alveolitis, but macrophages were dominant among inflammatory
cells. In contrast, the H1N1-infected mice had minimal lesions of
mild peribronchiolar lymphocytic infiltrates and mild lympho-
cytic alveolitis without bronchiolar epithelial necrosis (Fig. 5H).
Thus, histopathology data confirm the continuing necrotic and
inflammatory processes in the lungs of H5N1-, H7N7-, and
H7N9-infected mice, especially the prominence of macrophages
in bronchioles and alveoli, but with some granulocytes, and the
resolution of the cellular inflammatory processes with only mini-
mal lesions in H1N1-infected mice.
Increased transcription of cytokine response genes and de-
creased transcription of coagulation and lipid metabolism
genes correlate with increased pathogenicity. Despite the simi-
larity of the NL219 and Anhui1 host responses to that ofMex4482
on day 1, infection with the H7 subtype viruses induced weight
loss in mice, while infection with Mex4482 did not. Thus, we hy-
pothesized that transcriptional changes that were common to An-
hui1, NL219, and VN1203 but absent from Mex4482 would be
contributors to disease and lethality. As some of the avian-virus-
infected animals perished on day 5, we focused our analysis on
days 1 and 3 to identify drivers of pathogenesis. As our group and
others have shown previously, a robust cytokine response cor-
relates with pathogenicity (21, 27, 37–39). We obtained similar
results in this study, though the differences in the cytokine and
interferon responses of the pathogenic viruses versus the non-
pathogenic virus were not as prominent as in previous studies
(Fig. 6A). Themost striking difference between the host responses
to the pathogenic versus the nonpathogenic viruses was that
Mex4482-infectedmice showed increased transcription of coagu-
lation genes and lipid metabolism genes on day 3, while the avian
virus-infectedmice showed decreased transcription of these genes
(Fig. 6B). Thus, viral pathogenicity correlated with lower expres-
sion of genes involved in lipid metabolism and coagulation. Im-
portantly, this signature was not identified in the cell culture
model (20), suggesting that it is driven by nonepithelial cell types
or by the cross talk between multiple cell types in the lung.
Our data therefore suggest that the avian viruses induce a three-
pronged transcriptomic signature of increased cytokine gene expres-
sion, decreased coagulation gene expression, and decreased lipid
metabolism gene expression. This may be a general property of
pathogenic influenza viruses, as Josset et al. also showed that lethality
of 1918 H1N1 and mouse-adapted pdm09H1N1 (A/California/04/
2009) is associated with lower expression of lipid metabolism and
coagulation genes (27). To determine the extent of the similarity
between the transcriptional responses to the avian viruses and
1918 virus, we generated a heatmapusing the gene list fromFig. 6B
and expression values from the work of Josset et al. This analysis
revealed the in-common suppression of coagulation and lipidme-
tabolism genes (Fig. 7), suggesting that this signature is character-
istic of pathogenic influenza viruses.
Prediction of potential antivirals against Anhui1 and other
pathogenic influenza virus strains.Current treatments for influ-
enza target the viral proteins, but this approach leads to the emer-
gence of antiviral resistance because of the inherentmalleability of
the virus genome. Since dysregulated host pathways contribute to
influenza pathogenesis, targeting the host response is a promising
therapeutic approach (27, 37–42). We hypothesized that mole-
cules that could reverse the common transcriptional response to
the pathogenic viruses could be used to treat severe H7N9 influ-
FIG 6 Pathogenic avian viruses induce a three-pronged signature of increased
expression of cytokine response genes and decreased expression of coagulation
and lipid metabolism genes. Heatmaps showing the expression levels of select
cytokine and IFN signaling genes at days 1 and 3 postinfection (A) and the
expression levels of selected coagulation and lipid metabolism genes at days 1
and 3 postinfection (B) from mice infected with H7N9 (A/Anhui/1/2013),
H7N7 (A/Netherlands/219/2003), H5N1 (A/Vietnam/1203/2004), and
pdm09H1N1 (A/Mexico/4482/2009).
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enza. To predict potential antivirals, we used IPA upstream regu-
lator analysis to identify drugs and chemicals that could be used to
treat infections caused by H7N9. The IPA database was queried
with the DE genes from days 1 and 3 postinfection in Anhui1-
infected mice, and we selected all the molecules annotated “drugs
and chemicals”with Z scores less than2.We identified 31 chem-
icals that were predicted to reverse transcriptional profiles associ-
ated with Anhui1 infection on days 1 and 3 postinfection;many of
these were also predicted to reverse host responses to the other
three viruses (Fig. 8). One of these molecules, minocycline, inhib-
its H7N9 replication in vitro (20). Six of these compounds, cande-
sartan, dobutamine, warfarin, glyburide, minocycline, and eptifi-
batide, are FDA-approved drugs that could potentially be
repurposed as treatments for H7N9 and other severe influenza
virus infections.
DISCUSSION
After theChinese government closed live-poultrymarkets inApril
2013, the number of cases of H7N9 influenza diminished. How-
ever, there was a sharp increase in H7N9 cases during the 2013-
2014 winter season. H7N9 has continued to circulate in the poul-
try population (9, 43, 44), raising the possibility of additional
human infections. Since H7 subtype viruses have sporadically
jumped to humans and caused severe disease (11), we need to
understand their pathogenicity so as to identify novel interven-
tions.
A striking result of our experiments was that all of the viruses
examined replicated to similar levels but induced different tran-
FIG 7 1918 H1N1 induces decreased expression of coagulation and lipid me-
tabolism genes. Heatmaps show the expression levels of selected coagulation
and lipid metabolism genes at days 1 and 3 postinfection from BALB/c mice
infected with 106 PFU of pathogenic 1918 H1N1 or nonpathogenic A/New
Jersey/8/76 (NJ76H1N1). The experiment is described in reference 27, and the
rawmicroarray data can be found at NCBI’s Gene Expression Omnibus under
GEO Series accession number GSE36328. Heatmaps were generated using the
gene list from panel B and expression values from reference 27.
FIG 8 Molecules predicted to reverse the lung transcriptomic response to H7N9 and other influenza viruses. Drug prediction was based on the expression
of known targets for molecules within the IPA database. For each virus, Z scores were calculated using log2FC expression of DE genes at days 1 and 3. A
negative Z score indicates that the molecule downregulates genes that were significantly upregulated after infection and/or upregulates genes that
were downregulated after infection. Thirty-one molecules were predicted to reverse the transcriptional profile associated with Anhui1 infection on days
1 and 3 postinfection. The Z scores associated with the other three viruses are also included for these 31 molecules. 1-Cyclopropyl-3*,
1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl)urea.
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scriptional responses in mice. Variation in morbidity and elicita-
tion of proinflammatory cytokines and chemokines in murine
lungs postinoculation among viruses which replicate to compara-
ble titers has been demonstrated previously (14, 26, 35, 45), but a
lack of in-depth transcriptomic analyses has limited our under-
standing of the responses that contribute to mammalian patho-
genesis. Data in a recent paper attributed the higher cytokine pro-
duction and pathogenicity induced byH5N1 versusH7N9 inmice
to 10-fold-better replication of H5N1 virus in that model (33).
This difference may be due in part to the virus strains used: we
used A/Anhui/1/2013 (H7N9) and A/Vietnam/1203/2004 (H5N1),
while Mok et al. used A/Shanghai/2/2013 (H7N9) and A/Hong
Kong/483/97 (H5N1). Anhui1 elicits more weight loss in mice
than Shanghai2 does and possesses a higher binding affinity than
Shangai2 for all 2,3- and 2,6-glycans tested (15, 19). Subtle
differences in receptor binding or other aspects of viral replication
may impact infection kinetics, allowing Anhui1 to replicate to
higher levels than Shangai2. Though virus load contributes to the
host response (27, 33, 46), virus intrinsic properties are also im-
portant. Because all four viruses we examined replicated to com-
parable titers, we were able to ascribe differences in host response
and pathogenicity to properties of the individual virus rather than
to the quantity of virus present in the lungs. Our findings also
illustrate a more general point: differences in the host response
cannot be attributed solely to differences in viral replication.
Profiling of cultured airway cells had revealed that the epithe-
lial transcriptomic response to Anhui1 was highly specific to this
viral strain and that the Anhui1-induced response was more sim-
ilar to the response to human H3N2 than to the responses to
NL219 and VN1203 (20). Our current study revealed that addi-
tional differences and similarities in the responses arise among
Anhui1, NL219, and VN1203 when the whole lung is profiled.
VN1203, Anhui1, andNL219 were equally pathogenic inmice at a
dose of 105 PFU, though there were differences in the quality and
magnitude of the transcriptional responses that they elicited.
When we compared the intensities of the host response using
MDS and the number of DE genes, it was apparent that the host
response to H5N1, particularly with respect to the interferon and
cytokine responses, wasmore robust than the host response to the
H7 subtype viruses. This is in accord with in vitro and ex vivo
studies that have shown reduced induction of innate host re-
sponses among H7 subtype viruses compared with other virus
subtypes in human respiratory and other cell types (20, 47–50).
The lung host responses to H7N9 and H7N7 viruses were largely
similar, but H7N7 induced a greater interferon and cytokine re-
sponse than H7N9 on day 1. We also found that responses to the
H7 subtype viruses share features with the responses to both
VN1203 and Mex4482, which are strikingly different from each
other. Our data therefore indicate that H7 subtype host responses
are closer to the Mex4482 response than the VN1203 response
early in infection but evolve to be similar to the VN1203 response
as infection proceeds. Notably, though Anhui1 is a low-pathoge-
nicity avian virus (LPAI) that does not cause disease in chickens,
themurine response to it resembles themurine response to highly
pathogenic NL219. This supports previous experiments showing
that the basic sequence motif, which determines H7 subtype vir-
ulence in chickens, is not necessary for a virulent phenotype in
mammals (23, 26).
Acute-phase serum samples from H7N9- and H5N1-infected
patients contain elevated levels of inflammatory cytokines (9, 15,
51). Dysregulated cytokine responses are markers of influenza
pathogenicity across multiple influenza virus serotypes (reviewed
in reference 52). Our transcriptomic analysis corroborates previ-
ous studies showing that mice infected with H7N9, H5N1, and
H7N7 also exhibit hypercytokinemia (13, 23, 33, 34, 36).
While the roles of lipid metabolism in influenza pathogenesis
have been the subject of recent study, they are not well defined.
ApoL2 inhibits apoptosis in human bronchial epithelial cells,
while an ApoA1 mimetic inhibits the inflammatory response of
pneumocytes (53, 54). Two recent papers also implicated lipid
metabolism in influenza pathogenesis (40, 41), and protectin D1
(PD1), a fatty acid that inhibits monocyte and lymphocyte traf-
ficking (55), was shown to decrease influenza virus replication and
disease severity. Interleukin 1 (IL-1) receptor 1 knockout (IL-1R
KO) mice show an increased susceptibility to influenza, and this
correlates with decreased expression of lipid metabolism genes
such as the ApoA2 and ApoH genes (56). Our group has previ-
ously shown that decreased expression of lipid metabolism genes
is associated with the virulence ofmouse-adapted pdm09H1N1 as
well as 1918 H1N1 (27). Our current data extend the protective
role of lipidmetabolism to avian influenza viruses. Increased lipid
metabolism may promote survival by increasing the cellular
building blocks that are required for repairing damaged lung tis-
sue and/or by producing anti-inflammatory lipids such as PD1
that diminish cytokine dysregulation and immune cell infiltra-
tion.
Coagulopathy has been observed in some cases of severeH7N9
andH5N1 influenza (3, 9, 57). Depressed coagulation factor tran-
scription in the lungs of mice infected with pathogenic avian vi-
ruses may offer insight into these observations, especially since
this has also been observed in mice infected with highly patho-
genic H1N1 strains, such as the 1918 virus (27). Though the liver
is the primary site of fibrinogen synthesis, lung epithelial cells also
produce fibrinogen in response to inflammation, IL-6 treatment,
and infection with severe acute respiratory syndrome coronavirus
(SARS-CoV) or Pneumocystis jirovecii (58–61). H7N9 infection
does not affect coagulation factor transcription in airway epithe-
lial cells (20), suggesting that this signature is produced by other
cells such as alveolar macrophages, which produce coagulation
factors in response to stimulation (62). Coagulation factors may
facilitate lung repair by increasing the conversion of fibrinogen
into fibrin matrices, which act as scaffolds upon which damaged
epithelium is repaired (63, 64). Additionally, increased coagula-
tion factor expression could promote survival by decreasing infec-
tion-induced vascular permeability. The endothelial cells of the
vasculature are considered central regulators of influenza-medi-
ated cytokine dysregulation because increased vascular permea-
bility leads to increased inflammatory cell recruitment (65). Acti-
vated protease-activated receptor 1 (PAR1) converts plasminogen
(PLG) to plasmin, which increases vascular permeability through
fibrinolysis, and PLGKOmice and PAR1KOmice show increased
survival when infected with H5N1, H3N2, or H1N1 influenza
virus (66, 67). Pathogenic influenza virus infections could in-
crease fibrinolysis, leading to vascular permeability, increased cel-
lular infiltration, and irreparable lung damage. The increased ex-
pression of fibrinogen and other coagulation factors during
nonpathogenic influenza virus infections may counteract fibrino-
lysis to decrease inflammation and promote survival. Fibrinogen
treatment decreases bacterially induced lung pathogenesis (68), so
it may be worth evaluating as a treatment for severe influenza.
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We identified 31 drugs that were predicted to reverse the host
response to Anhui1 in mice. Six of the predicted drugs are FDA
approved, and of these six, dobutamine, candesartan, and mino-
cycline have been shown to reduce lung damage in different ex-
perimental models. Dobutamine is a -2 agonist that improves
lung function in a rat lung model of hypothermia and ischemia
(69), and it has been used to resolve acute lung damage in a human
patient (70). Candesartan is an angiotensin receptor blocker that
has been shown to reduce lung arteriolar hypertrophy in rats (71).
Minocycline, a tetracycline antibiotic, is an attractive candidate
because it inhibits Anhui1 replication in human airway cells (20)
and decreases lung injury in mice (72).
In conclusion, our data suggest that severe influenza caused by
avian viruses, such as H7N9, H7N7, and H5N1, or highly patho-
genic human viruses, such as the 1918 virus, is associated with
decreased transcription of lipid metabolism and coagulation
genes and increased transcription of inflammatory cytokine
genes.We have identified several FDA-approved compounds that
may target this signature and which could be used to treat disease
caused by H7N9 and other pathogenic influenza virus strains.
Further study of the cross talk of cytokine signaling, coagulation
response, and lipidmetabolism in influenza pathogenesis will lead
to a better understanding of severe influenza and could aid in the
discovery of novel host-directed therapeutics for the treatment of
severe influenza.
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